-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Zhitong Finance App, Shiyao Innovation (300765.SZ) announced that the company's holding subsidiary, Shiyao Group Jushi Biopharmaceutical Co., Ltd. (“Jushi Biotech”), received a milestone payment of 15 million US dollars from Corbus Pharmaceuticals, Inc. (“Corbus”) on November 18, 2026. Previously, Jushi Biotech has received a total of 17.5 million US dollars in down payments and milestone payments from Corbus under the exclusive licensing agreement (not including this payment). The collection is expected to have a positive impact on the company's performance and financial position.
Share
Listen to the news
According to Zhitong Finance App, Shiyao Innovation (300765.SZ) announced that the company's holding subsidiary, Shiyao Group Jushi Biopharmaceutical Co., Ltd. (“Jushi Biotech”), received a milestone payment of 15 million US dollars from Corbus Pharmaceuticals, Inc. (“Corbus”) on November 18, 2026. Previously, Jushi Biotech has received a total of 17.5 million US dollars in down payments and milestone payments from Corbus under the exclusive licensing agreement (not including this payment). The collection is expected to have a positive impact on the company's performance and financial position.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending